Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02162329 · ClinicalTrials.gov registry record · NA
Effects of Meditation on Cognitive Function and Quality of Life
A NA study of Breast Cancer, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
- 2
- Study locations
NCT02162329: Completed NA study of Breast Cancer, sponsored by M.D. Anderson Cancer Center.
NCT02162329 is a NA study of Breast Cancer that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 35 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02162329, a NA study of Breast Cancer, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this research study is to test Tibetan meditation as a therapy to teach cancer patients to change their brain functioning and to improve quality of life. Researchers want to compare the cancer patients' outcomes to people who have never had cancer.
Conditions Studied
Interventions
- BEHAVIORAL Questionnaires
- PROCEDURE Electroencephalography (EEG)
- PROCEDURE Magnetic Resonance Imaging (fMRI
- BEHAVIORAL Meditation Classes
Study Locations (2)
Texas
- University of Texas MD Anderson Cancer Center - Houston
Other
- Hospital Israelita Albert Einstein (HIAE) - São Paulo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2013-10-22 |
| Est. Completion | 2022-10-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02162329
The ClinicalTrials.gov registry entry for NCT02162329 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 4 interventions - of which Questionnaires is the first listed.
NCT02162329 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Texas, Other.
Frequently Asked Questions
What is clinical trial NCT02162329 about?
NCT02162329 is a clinical study titled "Effects of Meditation on Cognitive Function and Quality of Life". The goal of this research study is to test Tibetan meditation as a therapy to teach cancer patients to change their brain functioning and to improve quality of life. Researchers want to compare the cancer patients' outcomes to people who have never had cancer.
What is the current status of trial NCT02162329?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2013-10-22. Estimated completion is 2022-10-18.
What conditions does trial NCT02162329 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT02162329?
The interventions under investigation include: Questionnaires (BEHAVIORAL), Electroencephalography (EEG) (PROCEDURE), Magnetic Resonance Imaging (fMRI (PROCEDURE), Meditation Classes (BEHAVIORAL).
Who is sponsoring clinical trial NCT02162329?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02162329 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.